Search research articles
Contact Us
Filters
Showing results (101-110 of 111) with videos related to
Page
of 12
Sort By:
Der Urologe. Ausg. A
|
July 22, 2006
[100 years urology in Germany. Neuro-urology]
J Pannek, P M Braun, W Diederichs, et al.
Der Urologe. Ausg. A
|
February 14, 2007
[Botulinum toxin for the treatment of neurogenic detrusor hyperactivity. Consensus paper on use for neurogenic bladder dysfunction]
K-D Sievert, J Bremer, H Burgdörfer, et al.
European Urology
|
November 19, 2004
Increased expression of connexin 43 in the overactive neurogenic detrusor
A Haferkamp, J Mundhenk, P J Bastian, et al.
Spinal Cord
|
July 31, 2013
International Spinal Cord Injury Urinary Tract Infection Basic Data Set
L L Goetz, D D Cardenas, M Kennelly, et al.
Urology
|
December 1, 1996
The role of free/total prostate-specific antigen ratio in the prediction of final pathologic stage for men with clinically localized prostate cancer
J Pannek, E N Subong, K A Jones, et al.
Urology
|
December 31, 1997
Molecular forms of prostate-specific antigen and human kallikrein 2 (hK2) in urine are not clinically useful for early detection and staging of prostate cancer
J Pannek, H G Rittenhouse, C L Evans, et al.
Prostate Cancer and Prostatic Diseases
|
December 24, 2002
Prospective evaluation of percent free-PSA and complexed-PSA for early detection of prostate cancer
A W Partin, M K Brawer, E N P Subong, et al.
The Journal of Urology
|
July 2, 1998
Influence of finasteride on free and total serum prostate specific antigen levels in men with benign prostatic hyperplasia
J Pannek, L S Marks, J D Pearson, et al.
Der Urologe. Ausg. A
|
August 5, 2003
[Prostate cancer diagnosis using ultrasound elastography. Introduction of a novel technique and first clinical results]
H J Sommerfeld, J M Garcia-Schürmann, J Schewe, et al.
Der Urologe. Ausg. A
|
February 19, 2015
[Neurogenic bladder function disorders in patients with meningomyelocele: S2k guidelines on diagnostics and therapy]
R Stein, C Assion, R Beetz, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 111) with videos related to
Sort By:
Page
of 12
Der Urologe. Ausg. A
|
July 22, 2006
[100 years urology in Germany. Neuro-urology]
J Pannek, P M Braun, W Diederichs, et al.
Der Urologe. Ausg. A
|
February 14, 2007
[Botulinum toxin for the treatment of neurogenic detrusor hyperactivity. Consensus paper on use for neurogenic bladder dysfunction]
K-D Sievert, J Bremer, H Burgdörfer, et al.
European Urology
|
November 19, 2004
Increased expression of connexin 43 in the overactive neurogenic detrusor
A Haferkamp, J Mundhenk, P J Bastian, et al.
Spinal Cord
|
July 31, 2013
International Spinal Cord Injury Urinary Tract Infection Basic Data Set
L L Goetz, D D Cardenas, M Kennelly, et al.
Urology
|
December 1, 1996
The role of free/total prostate-specific antigen ratio in the prediction of final pathologic stage for men with clinically localized prostate cancer
J Pannek, E N Subong, K A Jones, et al.
Urology
|
December 31, 1997
Molecular forms of prostate-specific antigen and human kallikrein 2 (hK2) in urine are not clinically useful for early detection and staging of prostate cancer
J Pannek, H G Rittenhouse, C L Evans, et al.
Prostate Cancer and Prostatic Diseases
|
December 24, 2002
Prospective evaluation of percent free-PSA and complexed-PSA for early detection of prostate cancer
A W Partin, M K Brawer, E N P Subong, et al.
The Journal of Urology
|
July 2, 1998
Influence of finasteride on free and total serum prostate specific antigen levels in men with benign prostatic hyperplasia
J Pannek, L S Marks, J D Pearson, et al.
Der Urologe. Ausg. A
|
August 5, 2003
[Prostate cancer diagnosis using ultrasound elastography. Introduction of a novel technique and first clinical results]
H J Sommerfeld, J M Garcia-Schürmann, J Schewe, et al.
Der Urologe. Ausg. A
|
February 19, 2015
[Neurogenic bladder function disorders in patients with meningomyelocele: S2k guidelines on diagnostics and therapy]
R Stein, C Assion, R Beetz, et al.
Page
of 12